However, testing of the vaccine developed by AstraZeneca with the University of Oxford in Britain would continue despite the volunteer’s death
3.5 million doses will arrive in Greece by the end of 2020
Unexpected side-effects after a drug has regulatory approval are rare
Experts are concerned that the company has not been more forthcoming about two more participants who became seriously ill
It was now safe for the tests to proceed, the company announced on Saturday
"This is not the first time this has happened to the Oxford vaccine"
“This is a unique situation where we as a company simply cannot take the risk if in four years the vaccine is showing side effects”!
The agreement is a consequence of AstraZeneca's existing agreement with the European Alliance for Exclusive Vaccine